TTR and amyloidosis: The levels of transthyretin have been shown to be altered in several amyloid diseases, such as familial amyloid cardiomyopathy, polyneuropathy and senile systemic amyloidosis, where transthyretin is deposited onto tissues as toxic aggregates11, 16.